Key stats
Market capitalization
91.642MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
10.27
Basic EPS (TTM)
0.21USD
About Intercure Ltd
ISIN
IL0011063760
Sector
Health Technology
Industry
Medical Specialties
Website
intercure.co
CEO
Alexander Rabinovitch
Headquarters
Herzliya
Founded
1994
InterCure Ltd. engages in the business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies and Investments in Medical Cannabis Companies segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0